ALPHARETTA, GA – Sanuwave Health Inc. secured a patent for a blood sterilization technique involving external shock waves.
The Alpharetta, Ga.-based company develops extracorp real shock wave technology for chronic wound care, cardiovascular, neurological and orthopedic conditions. It reported Thursday the U.S. Patent and Trademark Officeapproved a patent called “Method and Devices for Cleaning and Sterilization with Shock Waves.” The patent relates to a new method that sterilizes blood by applying external shock waves to destroy blood pathogens contained in bags, pipes and tubes. The patent lasts to July 2031.
“This marks the first of many patents that we intend to add to our intellectual property portfolio to broaden the use of our technology beyond wound care and regenerative medicine,” said Joseph Chiarelli, Sanuwave CEO, in a statement.
“… This new patent protects a novel capability of our proprietary technology and has the potential to be a significant asset for our company. Blood sterilization represents a large, unmet medical need.”
Chiarelli said the company’s shock wave technology disrupts the outer membrane of bacteria and viruses to kill them.